 |
Previous Article | Next Article 
Volume 17, Number 1,
Issue of January 1, 1997
pp. 383-390
Copyright ©1997 Society for Neuroscience
Deprivation State Switches the Neurobiological Substrates
Mediating Opiate Reward in the Ventral Tegmental Area
Received July 18, 1996; revised Sept. 11, 1996; accepted Oct. 3, 1996.
Karim Nader and
Derek van der
Kooy
Neurobiology Research Group, Department of Anatomy and Cell
Biology, University of Toronto, Toronto, Ontario, Canada M5S 1A8
The population of mesolimbic dopaminergic neurons is believed to be
a primary site at which opiates produce their rewarding effects. Using
an unbiased, counterbalanced place conditioning paradigm, we reexamined
the contribution made by these cells to the rewarding properties of
morphine. Rats were conditioned such that distinct environments were
paired with an intra-ventral tegmental area (VTA) microinfusion of
either 500 ng per 0.5 µl per side morphine or 0.5 µl per side
sterile saline. Furthermore, rats were conditioned either previously
drug-naive or while in a motivational state of opiate dependence and
withdrawal. We report that pretreatment with the broad-spectrum
dopamine antagonist -flupentixol blocked the acquisition of
conditioned place preferences for environments paired with morphine
microinjections directly into the VTA in opiate-dependent and
withdrawn, but not in previously drug-naive, rats. Lesions of the
tegmental pedunculopontine nucleus (TPP) produced exactly the opposite
pattern of results. TPP lesions blocked the acquisition of conditioned
place preferences for environments paired with VTA morphine
microinjections in previously drug-naive, but not in opiate-dependent
and withdrawn, rats. These data double-dissociate two independent
reward substrates within the VTA itself and suggest that deprivation
state selects which of these two substrates will be active.
Furthermore, these findings are the first to demonstrate a
nondopaminergic substrate for reward within the VTA itself.
Key words:
-flupentixol;
morphine;
reward;
withdrawal;
place
preference;
tegmental pedunculopontine
This article has been cited by other articles:

|
 |

|
 |
 
S. Steidl and J. S. Yeomans
M5 Muscarinic Receptor Knockout Mice Show Reduced Morphine-Induced Locomotion but Increased Locomotion after Cholinergic Antagonism in the Ventral Tegmental Area
J. Pharmacol. Exp. Ther.,
January 1, 2009;
328(1):
263 - 275.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. B. Margolis, H. L. Fields, G. O. Hjelmstad, and J. M. Mitchell
{delta}-Opioid Receptor Expression in the Ventral Tegmental Area Protects Against Elevated Alcohol Consumption
J. Neurosci.,
November 26, 2008;
28(48):
12672 - 12681.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. B. Margolis, H. Lock, G. O. Hjelmstad, and H. L. Fields
The ventral tegmental area revisited: is there an electrophysiological marker for dopaminergic neurons?
J. Physiol.,
December 15, 2006;
577(3):
907 - 924.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. B. Margolis, G. O. Hjelmstad, A. Bonci, and H. L. Fields
Both Kappa and Mu Opioid Agonists Inhibit Glutamatergic Input to Ventral Tegmental Area Neurons
J Neurophysiol,
June 1, 2005;
93(6):
3086 - 3093.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. A. Kim, K. A. Pollak, G. O. Hjelmstad, and H. L. Fields
A single cocaine exposure enhances both opioid reward and aversion through a ventral tegmental area-dependent mechanism
PNAS,
April 13, 2004;
101(15):
5664 - 5669.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. B. Margolis, G. O. Hjelmstad, A. Bonci, and H. L. Fields
{kappa}-Opioid Agonists Directly Inhibit Midbrain Dopaminergic Neurons
J. Neurosci.,
November 5, 2003;
23(31):
9981 - 9986.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. H. L. Sellings and P. B. S. Clarke
Segregation of Amphetamine Reward and Locomotor Stimulation between Nucleus Accumbens Medial Shell and Core
J. Neurosci.,
July 16, 2003;
23(15):
6295 - 6303.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. R. Laviolette, T. O. Alexson, and D. van der Kooy
Lesions of the Tegmental Pedunculopontine Nucleus Block the Rewarding Effects and Reveal the Aversive Effects of Nicotine in the Ventral Tegmental Area
J. Neurosci.,
October 1, 2002;
22(19):
8653 - 8660.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Zangen, S. Ikemoto, J. E. Zadina, and R. A. Wise
Rewarding and Psychomotor Stimulant Effects of Endomorphin-1: Anteroposterior Differences within the Ventral Tegmental Area and Lack of Effect in Nucleus Accumbens
J. Neurosci.,
August 15, 2002;
22(16):
7225 - 7233.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
U. Shalev, J. W. Grimm, and Y. Shaham
Neurobiology of Relapse to Heroin and Cocaine Seeking: A Review
Pharmacol. Rev.,
March 1, 2002;
54(1):
1 - 42.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. M. van Ree, M. A. F. M. Gerrits, and L. J. M. J. Vanderschuren
Opioids, Reward and Addiction: An Encounter of Biology, Psychology, and Medicine
Pharmacol. Rev.,
June 1, 1999;
51(2):
341 - 396.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|

|